Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.

about

Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.

Item

http://www.wikidata.org/entity/Q47130373

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@en

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@nl

type

Item

label

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@en

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@nl

prefLabel

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@en

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@nl

P1476

Short-Term Choriocapillaris Ch ...... alf-Dose Photodynamic Therapy.

@en

P2093

Camilla Alovisi

http://www.w3.org/2001/XMLSchema#string

Carlo Lavia

http://www.w3.org/2001/XMLSchema#string

Chiara M Eandi

http://www.w3.org/2001/XMLSchema#string

Luca Musso

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for central serous chorioretinopathy: a network meta-analysis

Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Photodynamic therapy for chronic central serous chorioretinopathy.

Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study

Long-term follow-up of central serous chorioretinopathy.

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration.

Central serous chorioretinopathy: update on pathophysiology and treatment.

P31

scholarly article

P356

10.3390/IJMS18112468

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Nassisi

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29156649

http://www.w3.org/2001/XMLSchema#string

P932

5713434

http://www.w3.org/2001/XMLSchema#string